Literature DB >> 3638964

The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.

M K Pangburn, H J Müller-Eberhard.   

Abstract

The association of Factor B with C3b (the major fragment of complement component C3) in the presence of Mg2+ results in the formation of a bimolecular zymogen, C3b,B, which is activated by the serine proteinase Factor D, generating the C3 convertase, C3b,Bb (EC 3.4.21.47). Cleavage of native C3 by the C3 convertase was monitored by recording the increase in fluorescence associated with C3b formation in the presence of the fluorescent probe 8-anilinonaphthalene-1-sulphonate. Measurements of initial rates of C3b formation at various C3 concentrations were analysed in accordance with the Michaelis-Menten equation, yielding kcat. = 1.78 +/- 0.08 s-1, Km = 5.86 X 10(-6) M and turnover number = 107 min-1. The assay was used to measure the Ki values of a variety of proteinase inhibitors. The C3 convertase has a short half-life, owing to spontaneous dissociation of the complex. The t1/2 and kcat./Km of the enzyme were determined by fitting an equation modelling both the kinetic reaction and enzyme decay to the fluorimetrically measured progress curve. The enzyme, C3b,Bb, exhibited a t1/2 of 90 +/- 2 s and a kcat./Km of 31.1 X 10(4) +/- 0.8 X 10(4) M-1 X s-1 at physiological pH, ionic strength and temperature. The enzyme that initiates activation of the alternative pathway, C3(H2O),Bb, was also examined. It was slightly less stable (t1/2 = 77 +/- 3 s) and exhibited only half the activity of C3b,Bb (kcat./Km = 16.3 X 10(4) +/- 1.0 X 10(4) M-1 X s-1).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3638964      PMCID: PMC1146747          DOI: 10.1042/bj2350723

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  The serine protease nature of the C3 and C5 convertases of the classical and alternative complement pathways.

Authors:  R G Medicus; O Götze; H J Müller-Eberhard
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

2.  Inhibition of the classical and alternative pathways by amino acids and their derivatives.

Authors:  Y Takada; Y Arimoto; H Mineda; A Takada
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

3.  Leupeptin inhibits the C3/5 convertase CVFBb of the complement system.

Authors:  L H Caporale
Journal:  Biochim Biophys Acta       Date:  1981-07-24

4.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

5.  The alternative pathway C3/C5 convertase: chemical basis of factor B activation.

Authors:  P H Lesavre; T E Hugli; A F Esser; H J Müller-Eberhard
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

6.  A reexamination of the role of magnesium in the human alternative pathway of complement.

Authors:  E L Pryzdial; D E Isenman
Journal:  Mol Immunol       Date:  1986-01       Impact factor: 4.407

7.  C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.

Authors:  Z Fishelson; H J Müller-Eberhard
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

8.  Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties.

Authors:  D E Isenman; D I Kells; N R Cooper; H J Müller-Eberhard; M K Pangburn
Journal:  Biochemistry       Date:  1981-07-21       Impact factor: 3.162

9.  Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies.

Authors:  D E Isenman
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

10.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more
  50 in total

1.  New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.

Authors:  H Jing; Y Xu; M Carson; D Moore; K J Macon; J E Volanakis; S V Narayana
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  Structures of the asparagine-linked oligosaccharides of guinea-pig factor B of the alternative complement pathway.

Authors:  T Mizuochi; J Hamako; K Titani; M Matsushita; H Okada
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.

Authors:  Eva Torreira; Agustín Tortajada; Tamara Montes; Santiago Rodríguez de Córdoba; Oscar Llorca
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-09       Impact factor: 11.205

Review 4.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

Review 5.  How novel structures inform understanding of complement function.

Authors:  Elena Goicoechea de Jorge; Hugo Yebenes; Marina Serna; Agustín Tortajada; Oscar Llorca; Santiago Rodríguez de Córdoba
Journal:  Semin Immunopathol       Date:  2017-08-14       Impact factor: 9.623

Review 6.  Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.

Authors:  Brandon L Garcia; Kasra X Ramyar; Daniel Ricklin; John D Lambris; Brian V Geisbrecht
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  Spatiotemporal dynamics of complement C5a production within bacterial extracellular polymeric substance.

Authors:  Erin C Conrad; Yueh-Ya Hsu; David M Bortz; John G Younger
Journal:  J Innate Immun       Date:  2013-01-11       Impact factor: 7.349

8.  Analysis of complement deposition and processing on Chlamydia trachomatis.

Authors:  Mads Lausen; Mikkel Eggert Thomsen; Gunna Christiansen; Nichlas Karred; Allan Stensballe; Tue Bjerg Bennike; Svend Birkelund
Journal:  Med Microbiol Immunol       Date:  2020-11-18       Impact factor: 3.402

9.  The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module.

Authors:  Christoph Q Schmidt; Andrew P Herbert; Haydyn D T Mertens; Mara Guariento; Dinesh C Soares; Dusan Uhrin; Arthur J Rowe; Dmitri I Svergun; Paul N Barlow
Journal:  J Mol Biol       Date:  2009-10-14       Impact factor: 5.469

10.  Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.

Authors:  Suzan H M Rooijakkers; Jin Wu; Maartje Ruyken; Robert van Domselaar; Karel L Planken; Apostolia Tzekou; Daniel Ricklin; John D Lambris; Bert J C Janssen; Jos A G van Strijp; Piet Gros
Journal:  Nat Immunol       Date:  2009-06-07       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.